| Metric | Q3 2022 | Q2 2022 | Q3 2021 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $4.6B | — | $4.2B | — | 8.2% |
| Op. Income | $1.5B | — | $1.3B | — | 19.7% |
| Gross Margin | 57.2% | — | 63.5% | — | -6.3pp |
| Net Margin | 24.4% | — | 22.0% | — | 2.4pp |
| EPS (Diluted) | $0.30 | — | $0.25 | — | 20.3% |
| Free Cash Flow | $0 | — | $0 | — | — |
| Item | Amount |
|---|---|
| REVENUE | $4.6B |
| Cost of Revenue | $2.0B |
| GROSS PROFIT | $2.6B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $435M |
| SG&A Expenses | $435M |
| Other Expenses | $685M |
| Operating Expenses | $1.1B |
| Cost & Expenses | $3.1B |
| OPERATING INCOME | $1.5B |
| Interest Income | $3.7B |
| Interest Expense | $1.6B |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $1.5B |
| Income Tax Expense | $380M |
| Net Income from Continuing Ops | $1.1B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $1.1B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $1.1B |
| D&A | $0 |
| EBIT | $1.5B |
| EBITDA | $1.5B |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $4.6B |
| Cost of Revenue | $2.0B |
| GROSS PROFIT | $2.6B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $435M |
| SG&A Expenses | $435M |
| Other Expenses | $685M |
| Operating Expenses | $1.1B |
| Cost & Expenses | $3.1B |
| OPERATING INCOME | $1.5B |
| Interest Income | $3.7B |
| Interest Expense | $1.6B |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $1.5B |
| Income Tax Expense | $380M |
| Net Income from Continuing Ops | $1.1B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $1.1B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $1.1B |
| D&A | $0 |
| EBIT | $1.5B |
| EBITDA | $1.5B |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $1.1B |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$1.1B |
| Change in Working Capital | $0 |
| OPERATING CASH FLOW | $0 |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | $0 |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | $0 |
| FREE CASH FLOW | $0 |
| Net Change in Cash | $0 |
| Item | Amount |
|---|---|
| Cash & Equivalents | $0 |
| Short-Term Investments | $0 |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $0 |
| PP&E (Net) | $8M |
| Goodwill | $212.6K |
| Intangible Assets | $0 |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | -$8M |
| TOTAL NON-CURRENT ASSETS | $0 |
| TOTAL ASSETS | $2.8B |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $0 |
| Long-Term Debt | $332M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | -$332M |
| TOTAL NON-CURRENT LIABILITIES | $0 |
| TOTAL LIABILITIES | $2.5B |
| Common Stock | $791.7K |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $337M |
| TOTAL STOCKHOLDERS' EQUITY | $338M |
| Minority Interest | $986.3K |
| TOTAL EQUITY | $339M |
| TOTAL LIABILITIES & EQUITY | $2.8B |
| Total Debt | $332M |
| Net Debt | $332M |
